Kun-Hsing Yu and HMS colleagues used AI to rapidly determine a brain tumor’s molecular identity during surgery, propeling the development of precision oncology. The tool is CHARM (Cryosection Histopathology Assessment and Review Machine.) Currently, genetic sequencing...
Hatice Altug, Hilal Lashue, and EPFL colleagues have developed ImmunoSEIRA, an AI-enhanced, biosensing tool for the detection of misfolded proteins linked to Parkinson’s and Alzheimer’s disease. The researchers also claim that neural networks can quantify disease...
EPFL professor Grégoire Courtine has created a “digital bridge” which has allowed a man whose spinal cord damage left him with paraplegia, to walk. The brain–spine interface builds on previous work, which combined intensive training and a lower...
Adam Sonaband and Northwestern colleages used a skull-implantable ultrasound device to open the blood-brain barrier and repeatedly permeate critical regions of the human brain, to deliver intravenous chemotherapy to glioblastoma patients. This is the first study...
Hermona Soreq, Yonatan Loewenstein, and Hebrew University of Jerusalem colleagues have uncovered a sex-specific molecular mechanism leading to accelerated cognitive decline in women with Alzheimer’s disease. Current therapeutic protocols are based on structural changes in...
Aviv Mezer and Hebrew University colleagues used quantitative MRI to identify cellular changes in Parkinson’s disease. Their method enabled them to look at microstructures in the striatum, which is known to deteriorate during disease progression....
In a recent study, Boston University professor Robert Reinhart used tACS to stimulate brain activity in 150 people aged 65-88, resulting in memory improvements for one month. Stimulating the dorsolateral prefrontal cortex improved long-term memory, while stimulating...
MIT’s Dina Katabi has developed a non-contact, neural network-based system to detect Parkinson’s disease while a person is sleeping. By assessing nocturnal breathing patterns, the series of algorithms detects, and tracks the progression of, the disease —...
On July 6, 2022, Mount Sinai’s Shahram Majidi threaded Synchron‘s 1.5-inch-long, wire and electrode implant into a blood vessel in the brain of a patient with ALS. The goal is for the patient, who cannot speak or...
Early Parkinson’s Disease patients benefit significantly from levodopa, to replace dopamine to restore normal motor function. As PD progresses, the brain loses more dopamine-producing cells, which causes motor complications and unpredictable responses to levodopa....